• Biotalys submits first protein-based biocontrol registration package to the EPA

    Friday January 22nd 2021

  • Targeting Tau to keep neurons connected

    Thursday January 21st 2021

  • reMYND extends Series B funding to EUR 24 million

    Thursday January 21st 2021

  • NICE recommends Jyseleca® (filgotinib) on NHS in landmark decision for rheumatoid arthritis

    Thursday January 21st 2021

  • Blue Matter announces acquisition of AIM, a leading European supply chain consulting firm

    Wednesday January 20th 2021

  • Oxurion NV appoints Prof Alan Stitt as Chief Scientific Officer

    Wednesday January 20th 2021

  • BioStrand announces formation of scientific board

    Tuesday January 19th 2021

  • QbD breidt nog verder uit: QUERCUS Labo vervoegt QbD Group

    Tuesday January 19th 2021

  • Your news here?

  • Bone Therapeutics and Rigenerand sign partnership for cell therapy process development

    Thursday January 14th 2021

  • Celyad Oncology appoints Marina Udier, Ph.D., to Board of Directors

    Tuesday January 12th 2021

  • Bone Therapeutics treats first patient in ALLOB Phase IIb tibial fracture study

    Tuesday January 12th 2021


Strategic Partners